Llwytho...
Biosimilar and Follow-on Insulin: The Ins, Outs, and Interchangeability
Objective: To provide an overview of the differences between biosimilars and generics, and to summarize regulatory requirements and outstanding issues related to biosimilar insulins in the United States, including the issue of interchangeability. Data Sources: References were obtained using MEDLINE...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | J Pharm Technol |
|---|---|
| Prif Awduron: | , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
SAGE Publications
2018
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6313268/ https://ncbi.nlm.nih.gov/pubmed/34861004 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/8755122518802268 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|